|
| Liver polyploidy: Dr Jekyll or Mr Hide |
|
https://doi.org/10.18632/oncotarget.3809
Géraldine Gentric, and Chantal Desdouets
|
| 8430-8431 |
|
| Intracellular HMGB1: defender of client proteins and cell fate |
|
https://doi.org/10.18632/oncotarget.3836
Jeannette Messer, and Eugene Chang
|
| 8432-8433 |
|
| The microRNA feedback regulation of p63 in cancer progression |
|
https://doi.org/10.18632/oncotarget.3020
Changwei Lin, Xiaorong Li, Yi Zhang, Yihang Guo, Jianyu Zhou, Kai Gao, Jing Dai, Gui Hu, Lv Lv, Juan Du, and Yi Zhang
|
| 8434-8453 |
|
| Targeting Hsp90 in urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.3502
Mahmoud Chehab, Tiffany Caza, Kamil Skotnicki, Steve Landas, Gennady Bratslavsky, Mehdi Mollapour, and Dimitra Bourboulia
|
| 8454-8473 |
|
| MicroRNAs in apoptosis autophagy and necroptosis |
|
https://doi.org/10.18632/oncotarget.3523
Zhenyi Su, Zuozhang Yang, Yongqing Xu, Yongbin Chen, and Qiang Yu
|
| 8474-8490 |
|
| The biology and treatment of oligometastatic cancer |
|
https://doi.org/10.18632/oncotarget.3455
Diane K. Reyes, and Kenneth J. Pienta
|
| 8491-8524 |
|
| Kinaseindependent role of cyclin D1 in chromosomal instability and mammary tumorigenesis |
|
https://doi.org/10.18632/oncotarget.3267
Mathew C. Casimiro, Gabriele Di Sante, Marco Crosariol, Emanuele Loro, William Dampier, Adam Ertel, Zuoren Yu, Elizabeth A. Saria, Alexandros Papanikolaou, Zhiping Li, Chenguang Wang, Sankar Addya, Michael P. Lisanti, Paolo Fortina, Robert D. Cardiff, Aydin Tozeren, Erik S. Knudsen, Andrew Arnold, and Richard G. Pestell
|
| 8525-8538 |
|
| Pharmacological inhibition of p38 MAPK reduces tumor growth in patientderived xenografts from colon tumors |
|
https://doi.org/10.18632/oncotarget.3816
Jalaj Gupta, Ana Igea, Marilena Papaioannou, Pedro Pablo Lopez-Casas, Elisabet Llonch, Manuel Hidalgo, Vassilis G. Gorgoulis, and Angel R. Nebreda
|
| 8539-8551 |
|
| A mutation in the NADHdehydrogenase subunit 2 suppresses fibroblast aging |
|
https://doi.org/10.18632/oncotarget.3298
Marianne Schauer, Tina Kottek, Madeleine Schönherr, Animesh Bhattacharya, Saleh M. Ibrahim, Misa Hirose, Rüdiger Köhling, Georg Fuellen, Ulf Schmitz, and Manfred Kunz
|
| 8552-8566 |
|
| Antiβ2microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy |
|
https://doi.org/10.18632/oncotarget.3251
Mingjun Zhang, Jin He, Zhiqiang Liu, Yong Lu, Yuhuan Zheng, Haiyan Li, Jingda Xu, Huan Liu, Jianfei Qian, Robert Z. Orlowski, Larry W. Kwak, Qing Yi, and Jing Yang
|
| 8567-8578 |
|
| Prognostic and predictive values of long noncoding RNA LINC00472 in breast cancer |
|
https://doi.org/10.18632/oncotarget.3287
Yi Shen, Dionyssios Katsaros, Lenora W. M. Loo, Brenda Y. Hernandez, Clayton Chong, Emilie Marion Canuto, Nicoletta Biglia, Lingeng Lu, Harvey Risch, Wen-Ming Chu, and Herbert Yu
|
| 8579-8592 |
|
| Crosstalk between Desmoglein 2 and Patched 1 accelerates chemicalinduced skin tumorigenesis |
|
https://doi.org/10.18632/oncotarget.3309
Donna M. Brennan-Crispi, Claudia Hossain, Joya Sahu, Mary Brady, Natalia A. Riobo, and Mỹ G. Mahoney
|
| 8593-8605 |
|
| D2hydroxyglutarate is essential for maintaining oncogenic property of mutant IDHcontaining cancer cells but dispensable for cell growth |
|
https://doi.org/10.18632/oncotarget.3330
Shenghong Ma, Bowen Jiang, Wanglong Deng, Zhong-Kai Gu, Fei-Zhen Wu, Tingting Li, Yukun Xia, Hui Yang, Dan Ye, Yue Xiong, and Kun-Liang Guan
|
| 8606-8620 |
|
| DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/βcatenin signaling |
|
https://doi.org/10.18632/oncotarget.3281
Yu Liu, Rong Zhou, Xun Yuan, Na Han, Si Zhou, Hanxiao Xu, Mingzhou Guo, Shiying Yu, Cuntai Zhang, Tiejun Yin, and Kongming Wu
|
| 8621-8634 |
|
| RIPK3 expression in cervical cancer cells is required for PolyICinduced necroptosis IL1α release and efficient paracrine dendritic cell activation |
|
https://doi.org/10.18632/oncotarget.3249
Susanne V. Schmidt, Stefanie Seibert, Barbara Walch-Rückheim, Benjamin Vicinus, Eva-Maria Kamionka, Jennifer Pahne-Zeppenfeld, Erich-Franz Solomayer, Yoo-Jin Kim, Rainer M. Bohle, and Sigrun Smola
|
| 8635-8647 |
|
| Basal and therapydriven hypoxiainducible factor1α confers resistance to endocrine therapy in estrogen receptorpositive breast |
|
https://doi.org/10.18632/oncotarget.3257
Xiaoqing Jia, Qi Hong, Li Lei, Daqiang Li, Jianwei Li, Miao Mo, Yujie Wang, Zhimin Shao, Zhenzhou Shen, Jingyi Cheng, and Guangyu Liu
|
| 8648-8662 |
|
| Enhancement of tumor initiation and expression of KCNMA1 MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment |
|
https://doi.org/10.18632/oncotarget.3536
Wei-Ying Kuo, Chun-Yi Wu, Luen Hwu, Jhih-Shian Lee, Cheng-Han Tsai, Kang-Ping Lin, Hsin-Ell Wang, Teh-Ying Chou, Chun-Ming Tsai, Juri Gelovani, and Ren-Shyan Liu
|
| 8663-8675 |
|
| A novel role for microRNA1295p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional coactivators YAP and TAZ |
|
https://doi.org/10.18632/oncotarget.3254
Guosheng Tan, Xinping Cao, Qiangsheng Dai, Bing Zhang, Jianwen Huang, Shiqiu Xiong, Yong yu Zhang, Wei Chen, Jianyong Yang, and Heping Li
|
| 8676-8686 |
|
| The stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis |
|
https://doi.org/10.18632/oncotarget.3478
Kan He, Wenwen Lv, Dongni Zheng, Fei Cheng, Tao Zhou, Shoudong Ye, Qian Ban, Qilong Ying, Bei Huang, Lei Chen, Guohua Wu, and Dahai Liu
|
| 8687-8697 |
|
| Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERKmediated stabilization of Bcl2 protein by phosphorylation at Serine 87 |
|
https://doi.org/10.18632/oncotarget.3537
Chi-Chou Huang, De-Wei Wu, Po-Lin Lin, and Huei Lee
|
| 8698-8708 |
|
| Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer |
|
https://doi.org/10.18632/oncotarget.3325
Yunhee Cho, Hyun-Woo Lee, Hyeok-Gu Kang, Hye-Young Kim, Seok-Jun Kim, and Kyung-Hee Chun
|
| 8709-8721 |
|
| Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma |
|
https://doi.org/10.18632/oncotarget.2726
Ulrike Graab, Heidi Hahn, and Simone Fulda
|
| 8722-8735 |
|
| PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins |
|
https://doi.org/10.18632/oncotarget.3538
Valentina Zuco, Michelandrea De Cesare, Nadia Zaffaroni, Cinzia Lanzi, and Giuliana Cassinelli
|
| 8736-8749 |
|
| Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl2 to overcome CD40induced ABT199 resistance in mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.3275
David Chiron, Christelle Dousset, Carole Brosseau, Cyrille Touzeau, Sophie Maïga, Philippe Moreau, Catherine Pellat-Deceunynck, Steven Le Gouill, and Martine Amiot
|
| 8750-8759 |
|
| TRPM7 maintains progenitorlike features of neuroblastoma cells: implications for metastasis formation |
|
https://doi.org/10.18632/oncotarget.3315
Jeroen Middelbeek, Daan Visser, Linda Henneman, Alwin Kamermans, Arthur J. Kuipers, Peter M. Hoogerbrugge, Kees Jalink, and Frank N. van Leeuwen
|
| 8760-8776 |
|
| Overexpression of Rad51C splice variants in colorectal tumors |
|
https://doi.org/10.18632/oncotarget.3209
Arjun Kalvala, Li Gao, Brittany Aguila, Tyler Reese, Gregory A. Otterson, Miguel A. Villalona-Calero, and Wenrui Duan
|
| 8777-8787 |
|
| Targeted therapy of glioblastoma stemlike cells and tumor nonstem cells using cetuximabconjugated ironoxide nanoparticles |
|
https://doi.org/10.18632/oncotarget.3554
Milota Kaluzova, Alexandros Bouras, Revaz Machaidze, and Costas G. Hadjipanayis
|
| 8788-8806 |
|
| Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3556
Si-Rui Ma, Wei-Ming Wang, Cong-Fa Huang, Wen-Feng Zhang, and Zhi-Jun Sun
|
| 8807-8821 |
|
| The attenuated hepatocellular carcinomaspecific Listeria vaccine LmddMPFG prevents tumor occurrence through immune regulation of dendritic cells |
|
https://doi.org/10.18632/oncotarget.3558
Xin Wan, Ci Cheng, Zhe Lin, Runqiu Jiang, Wei Zhao, Xin Yan, Junwei Tang, Kun Yao, Beicheng Sun, and Yun Chen
|
| 8822-8838 |
|
| Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxylterminal deletion mutants |
|
https://doi.org/10.18632/oncotarget.3559
Angela K.J. Park, Joshua M. Francis, Woong-Yang Park, Joon-Oh Park, and Jeonghee Cho
|
| 8839-8850 |
|
| The protooncogene cSrc and its downstream signaling pathways are inhibited by the metastasis suppressor NDRG1 |
|
https://doi.org/10.18632/oncotarget.3316
Wensheng Liu, Fei Yue, Minhua Zheng, Angelica Merlot, Dong-Hun Bae, Michael Haung, Darius Lane, Patric Jansson, Goldie Yuan Lam Lui, Vera Richardson, Sumit Sahni, Danuta Kalinowski, Zaklina Kovacevic, and Des. R. Richardson
|
| 8851-8874 |
|
| MicroRNA profiling identifies MiR195 suppresses osteosarcoma cell metastasis by targeting CCND1 |
|
https://doi.org/10.18632/oncotarget.3560
Kang Han, Xiang Chen, Na Bian, Baoan Ma, Tongtao Yang, Chengkui Cai, QingYu Fan, Yong Zhou, and TingBao Zhao
|
| 8875-8889 |
|
| Dual effects of collagenase3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry |
|
https://doi.org/10.18632/oncotarget.3189
Xiulan Zhao, Baocun Sun, Yanlei Li, Yanrong Liu, Danfang Zhang, Xudong Wang, Qiang Gu, Jianmin Zhao, Xueyi Dong, Zhiyong Liu, and Na Che
|
| 8890-8899 |
|
| Macrophages promote benzopyreneinduced tumor transformation of human bronchial epithelial cells by activation of NFκB and STAT3 signaling in a bionic airway chip culture and in animal models |
|
https://doi.org/10.18632/oncotarget.3561
Encheng Li, Zhiyun Xu, Hui Zhao, Zhao Sun, Lei Wang, Zhe Guo, Yang Zhao, Zhancheng Gao, and Qi Wang
|
| 8900-8913 |
|
| MiR203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelialmesenchymal transition via SNAI2 |
|
https://doi.org/10.18632/oncotarget.3563
Hongzhan Liao, Yifeng Bai, Shengcong Qiu, Lei Zheng, Lianyan Huang, Tianzhu Liu, Xin Wang, Yanting Liu, Ningbo Xu, Xiaohui Yan, and Hongbo Guo
|
| 8914-8928 |
|
| Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization |
|
https://doi.org/10.18632/oncotarget.3369
Shilpa Bhatia, Nimrah A. Baig, Olga Timofeeva, Elena B. Pasquale, Kellen Hirsch, Tobey J. MacDonald, Anatoly Dritschilo, Yi Chien Lee, Mark Henkemeyer, Brian Rood, Mira Jung, Xiao-Jing Wang, Marcel Kool, Olga Rodriguez, Chris Albanese, and Sana D. Karam
|
| 8929-8946 |
|
| Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion |
|
https://doi.org/10.18632/oncotarget.3250
Han-Ching Tseng, Nicholas Cacalano, and Anahid Jewett
|
| 8947-8959 |
|
| Dual targeting of microtubule and topoisomerase II by αcarboline derivative YCH337 for tumor proliferation and growth inhibition |
|
https://doi.org/10.18632/oncotarget.3264
Jun-Mei Yi, Xiao-Fei Zhang, Xia-Juan Huan, Shan-Shan Song, Wei Wang, Qian-Ting Tian, Yi-Ming Sun, Yi Chen, Jian Ding, Ying-Qing Wang, Chun-Hao Yang, and Ze-Hong Miao
|
| 8960-8973 |
|
| GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth |
|
https://doi.org/10.18632/oncotarget.3291
Junghui Koo, Xuerong Wang, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, and Shi-Yong Sun
|
| 8974-8987 |
|
| Novel harmine derivatives for tumor targeted therapy |
|
https://doi.org/10.18632/oncotarget.3276
Siwen Li, Aqin Wang, Fan Gu, Zhaohui Wang, Caiping Tian, Zhiyu Qian, Liping Tang, and Yueqing Gu
|
| 8988-9001 |
|
| Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer |
|
https://doi.org/10.18632/oncotarget.3282
Ping Chen, Tao Hu, Yupei Liang, Yanan Jiang, Yongfu Pan, Chunjie Li, Ping Zhang, Dongping Wei, Pei Li, Lak Shin Jeong, Yiwei Chu, Hui Qi, Meng Yang, Robert M. Hoffman, Ziming Dong, and Lijun Jia
|
| 9002-9017 |
|
| Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes |
|
https://doi.org/10.18632/oncotarget.3379
Divya Bhagirath, Xiangshan Zhao, William W. West, Fang Qiu, Hamid Band, and Vimla Band
|
| 9018-9030 |
|
| WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP9 and VEGFC |
|
https://doi.org/10.18632/oncotarget.3320
Ya-ling Tang, Xin Liu, Shi-yu Gao, Hao Feng, Ya-ping Jiang, Sha-sha Wang, Jing Yang, Jian Jiang, Xiang-rui Ma, Ya-jie Tang, Yu Chen, and Xin-hua Liang
|
| 9031-9044 |
|
| Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
|
https://doi.org/10.18632/oncotarget.3515
Jhon A. Ochoa-Alvarez, Harini Krishnan, John G. Pastorino, Evan Nevel, David Kephart, Joseph J. Lee, Edward P. Retzbach, Yongquan Shen, Mahnaz Fatahzadeh, Soly Baredes, Evelyne Kalyoussef, Masaru Honma, Martin E. Adelson, Mika K. Kaneko, Yukinari Kato, Mary Ann Young, Lisa Deluca-Rapone, Alan J. Shienbaum, Kingsley Yin, Lasse D. Jensen, and Gary S. Goldberg
|
| 9045-9060 |
|
| IL32α suppresses colorectal cancer development via TNFR1mediated death signaling |
|
https://doi.org/10.18632/oncotarget.3197
Hyung-Mun Yun, Kyung-Ran Park, Eun-Cheol Kim, Sang Bae Han, Do Young Yoon, and Jin Tae Hong
|
| 9061-9072 |
|
| Dual inhibition of HDAC and EGFR signaling with CUDC101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer |
|
https://doi.org/10.18632/oncotarget.3268
Lisa Zhang, Yaqin Zhang, Amit Mehta, Myriem Boufraqech, Sean Davis, Jing Wang, Ze Tian, Zhiya Yu, Matthew B. Boxer, Jeffrey A. Kiefer, John A. Copland, Robert C. Smallridge, Zhuyin Li, Min Shen, and Electron Kebebew
|
| 9073-9085 |
|
| Inhibition of the HER2YB1AR axis with Lapatinib synergistically enhances Enzalutamide antitumor efficacy in castration resistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.3602
Masaki Shiota, Jennifer L. Bishop, Ario Takeuchi, Ka Mun Nip, Thomas Cordonnier, Eliana Beraldi, Hidetoshi Kuruma, Martin E. Gleave, and Amina Zoubeidi
|
| 9086-9098 |
|
| The SOX17/miR3715p/SOX2 axis inhibits EMT stem cell properties and metastasis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3603
Yuling Li, Zhenbing Lv, Guoyang He, Jianmei Wang, Xiaojing Zhang, Guifeng Lu, Xiaoli Ren, Feifei Wang, Xiaohui Zhu, Yi Ding, Wenting Liao, Yanqing Ding, and Li Liang
|
| 9099-9112 |
|
| Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy |
|
https://doi.org/10.18632/oncotarget.3272
Frauke Nitzki, Ezequiel J. Tolosa, Nicole Cuvelier, Anke Frommhold, Gabriela Salinas-Riester, Steven A. Johnsen, Martin E. Fernandez-Zapico, and Heidi Hahn
|
| 9113-9124 |
|
| MicroRNA155 expression is independently predictive of outcome in chordoma |
|
https://doi.org/10.18632/oncotarget.3273
Eiji Osaka, Andrew D. Kelly, Dimitrios Spentzos, Edwin Choy, Xiaoqian Yang, Jacson K. Shen, Pei Yang, Henry J. Mankin, Francis J. Hornicek, and Zhenfeng Duan
|
| 9125-9139 |
|
| By activating matrix metalloproteinase7 shear stress promotes chondrosarcoma cell motility invasion and lung colonization |
|
https://doi.org/10.18632/oncotarget.3274
Pei-Pei Guan, Xin Yu, Jian-Jun Guo, Yue Wang, Tao Wang, Jia-Yi Li, Konstantinos Konstantopoulos, Zhan-You Wang, and Pu Wang
|
| 9140-9159 |
|
| The long noncoding RNA HNF1AAS1 regulates proliferation and metastasis in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.3247
Ying Wu, Hongbing Liu, Xuefei Shi, Yanwen Yao, Wen Yang, and Yong Song
|
| 9160-9172 |
|
| ANO1 interacts with EGFR and correlates with sensitivity to EGFRtargeting therapy in head and neck cancer |
|
https://doi.org/10.18632/oncotarget.3277
Anke Bill, Abraham Gutierrez, Sucheta Kulkarni, Carolyn Kemp, Debora Bonenfant, Hans Voshol, Umamaheswar Duvvuri, and L. Alex Gaither
|
| 9173-9188 |
|
| FLT3ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl1 pathway through STAT5 activation in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.3279
Ayako Nogami, Gaku Oshikawa, Keigo Okada, Shusaku Fukutake, Yoshihiro Umezawa, Toshikage Nagao, Tetsuya Kurosu, and Osamu Miura
|
| 9189-9205 |
|
| Mer receptor tyrosine kinase is frequently overexpressed in human nonsmall cell lung cancer confirming resistance to erlotinib |
|
https://doi.org/10.18632/oncotarget.3280
Shengzhi Xie, Yongwu Li, Xiaoyan Li, Linxiong Wang, Na Yang, Yadi Wang, and Huafeng Wei
|
| 9206-9219 |
|
| The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2 a potential tumor suppressor in the urinary bladder urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.3312
Chien-Feng Li, Wen-Jeng Wu, Wen-Ren Wu, Yu-Jing Liao, Lih-Ren Chen, Chun-Nung Huang, Ching-Chia Li, Wei-Ming Li, Hsuan-Ying Huang, Yi-Ling Chen, Shih-Shin Liang, Nan-Haw Chow, and Yow-Ling Shiue
|
| 9220-9239 |
|
| FBXW7mutated colorectal cancer cells exhibit aberrant expression of phosphorylatedp53 at Serine15 |
|
https://doi.org/10.18632/oncotarget.3284
Ningning Li, Federica Lorenzi, Eliana Kalakouti, Makhliyo Normatova, Roya Babaei-Jadidi, Ian Tomlinson, and Abdolrahman S. Nateri
|
| 9240-9256 |
|
| miR340 suppresses glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.3288
Daquan Huang, Shuwei Qiu, Ruiguang Ge, Lei He, Mei Li, Yi Li, and Ying Peng
|
| 9257-9270 |
|
| The mitochondrial carrier SLC25A10 regulates cancer cell growth |
|
https://doi.org/10.18632/oncotarget.3375
Xiaoshan Zhou, João A. Paredes, Shuba Krishnan, Sophie Curbo, and Anna Karlsson
|
| 9271-9283 |
|
| Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance |
|
https://doi.org/10.18632/oncotarget.3252
Fernando Gallardo, Andreina Padrón, Ricard Garcia-Carbonell, Cristina Rius, Abel González-Perez, Montserrat ArumÃ-Uria, Mar Iglesias, Lara Nonell, Beatriz Bellosillo, Sonia Segura, Ramon Maria Pujol, Nuria Lopez-Bigas, Joan Bertran, Anna Bigas, and LluÃs Espinosa
|
| 9284-9294 |
|
| A pentacyclic triterpene natural product ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis |
|
https://doi.org/10.18632/oncotarget.3261
Liping Xiang, Ting Chi, Qiao Tang, Xiang Yang, Minrui Ou, Xiufen Chen, Xiaobo Yu, Jianzhong Chen, Rodney J.Y. Ho, Jingwei Shao, and Lee Jia
|
| 9295-9312 |
|
| Upregulation of CD44 in the development of metastasis recurrence and drug resistance of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.3220
Yan Gao, Rosemary Foster, Xiaoqian Yang, Yong Feng, Jacson K. Shen, Henry J. Mankin, Francis J. Hornicek, Mansoor M. Amiji, and Zhenfeng Duan
|
| 9313-9326 |
|
| Coinhibition of pololike kinase 1 and Aurora kinases promotes mitotic catastrophe |
|
https://doi.org/10.18632/oncotarget.3313
Jingjing Li, Myung Jin Hong, Jeremy P.H. Chow, Wing Yu Man, Joyce P.Y. Mak, Hoi Tang Ma, and Randy Y.C. Poon
|
| 9327-9340 |
|
| A novel smallform NEDD4 regulates cell invasiveness and apoptosis to promote tumor metastasis |
|
https://doi.org/10.18632/oncotarget.3322
Chia-Jung Liao, Hsiang-Cheng Chi, Chung-Ying Tsai, Chi-De Chen, Sheng-Ming Wu, Yi-Hsin Tseng, Yang-Hsiang Lin, I-Hsiao Chung, Ching-Ying Chen, Syuan-Ling Lin, Ya-Hui Huang, and Kwang-Huei Lin
|
| 9341-9354 |
|
| Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development |
|
https://doi.org/10.18632/oncotarget.3323
Rong Deng, Xian Zhao, YingYing Qu, Cheng Chen, Changhong Zhu, Hailong Zhang, Haihua Yuan, Hui Jin, Xin Liu, Yanli Wang, Qin Chen, Jian Huang, and Jianxiu Yu
|
| 9355-9369 |
|
| HPV16 E5 deregulates the autophagic process in human keratinocytes |
|
https://doi.org/10.18632/oncotarget.3326
Francesca Belleudi, Monica Nanni, Salvatore Raffa, and Maria Rosaria Torrisi
|
| 9370-9386 |
|
| Gut bacteria require neutrophils to promote mammary tumorigenesis |
|
https://doi.org/10.18632/oncotarget.3328
Jessica R. Lakritz, Theofilos Poutahidis, Sheyla Mirabal, Bernard J. Varian, Tatiana Levkovich, Yassin M. Ibrahim, Jerrold M. Ward, Ellen C. Teng, Brett Fisher, Nicola Parry, Stephanie Lesage, Natalie Alberg, Sravya Gourishetti, James G. Fox, Zhongming Ge, and Susan E. Erdman
|
| 9387-9396 |
|
| CIP4 promotes metastasis in triplenegative breast cancer and is associated with poor patient prognosis |
|
https://doi.org/10.18632/oncotarget.3351
Otto L.D. Cerqueira, Peter Truesdell, Tomas Baldassarre, Santiago A. Vilella-Arias, Kathleen Watt, Jalna Meens, Harish Chander, Cynthia A.B. Osório, Fernando A. Soares, Eduardo M. Reis, and Andrew W.B. Craig
|
| 9397-9408 |
|
| Temporal regulation of HIF1 and NFκB in hypoxic hepatocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.3352
Yuan Jiang, Ying Zhu, Xinxin Wang, Juan Gong, Chunyan Hu, Bo Guo, Bo Zhu, and Yongsheng Li
|
| 9409-9419 |
|
| PTPROmediated autophagy prevents hepatosteatosis and tumorigenesis |
|
https://doi.org/10.18632/oncotarget.3353
Wenjie Zhang, Jiajie Hou, Xiaochen Wang, Runqiu Jiang, Yin Yin, Jie Ji, Lei Deng, Xingxu Huang, Ke Wang, and Beicheng Sun
|
| 9420-9433 |
|
| Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomibbased therapy in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.3319
Fei Li, Yan Xu, Ping Deng, Ye Yang, Weiwei Sui, Fengyan Jin, Mu Hao, Zengjun Li, Meirong Zang, Dehui Zhou, Zhimin Gu, Kun Ru, Jianxiang Wang, Tao Cheng, and Lugui Qiu
|
| 9434-9444 |
|
| MiR195 suppresses nonsmall cell lung cancer by targeting CHEK1 |
|
https://doi.org/10.18632/oncotarget.3255
Ben Liu, Jinli Qu, Fangxiu Xu, Yan Guo, Yu Wang, Herbert Yu, and Biyun Qian
|
| 9445-9456 |
|
| miR211 suppresses hepatocellular carcinoma by downregulating SATB2 |
|
https://doi.org/10.18632/oncotarget.3265
Guixing Jiang, Yunfu Cui, Xin Yu, Zhengrong Wu, Guoping Ding, and Liping Cao
|
| 9457-9466 |
|
| Quantification of cellular viability by automated microscopy and flow cytometry |
|
https://doi.org/10.18632/oncotarget.3266
Allan Sauvat, Yidan Wang, Florian Segura, Sabrina Spaggiari, Kevin Müller, Heng Zhou, Lorenzo Galluzzi, Oliver Kepp, and Guido Kroemer
|
| 9467-9475 |
|
| Lyn modulates Claudin2 expression and is a therapeutic target for breast cancer liver metastasis |
|
https://doi.org/10.18632/oncotarget.3269
Sébastien Tabariès, Matthew G. Annis, Brian E. Hsu, Christine E. Tam, Paul Savage, Morag Park, and Peter M. Siegel
|
| 9476-9487 |
|
| Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in nonHodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.3378
Christos Demosthenous, Jing Jing Han, Mary J. Stenson, Matthew J. Maurer, Linda E. Wellik, Brian Link, Kristen Hege, Ahmet Dogan, Eduardo Sotomayor, Thomas Witzig, and Mamta Gupta
|
| 9488-9501 |
|
| TRAILR2 promotes skeletal metastasis in a breast cancer xenograft mouse model |
|
https://doi.org/10.18632/oncotarget.3321
Hendrik Fritsche, Thorsten Heilmann, Robert J. Tower, Charlotte Hauser, Anja von Au, Doaa El-Sheikh, Graeme M. Campbell, Göhkan Alp, Denis Schewe, Sebastian Hübner, Sanjay Tiwari, Daniel Kownatzki, Susann Boretius, Walter Jonat, Dieter Adam, Walter Jonat, Thomas Becker, Claus C. Glüer, Margot Zöller, Anna Trauzold, Christian Schem, and Anna Trauzold
|
| 9502-9516 |
|
| Transcriptional coactivator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGFβ |
|
https://doi.org/10.18632/oncotarget.3367
Mei wang, Yang Liu, Jiahua Zou, Rui Yang, Fan Xuan, Yi Wang, Ning Gao, and Hongjuan Cui
|
| 9517-9530 |
|
| Podoplaninexpressing cancerassociated fibroblasts inhibit small cell lung cancer growth |
|
https://doi.org/10.18632/oncotarget.3371
Akiko Takahashi, Genichiro Ishii, Shinya Neri, Tatsuya Yoshida, Hiroko Hashimoto, Shigeki Suzuki, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Koichi Goto, Hironobu Ohmatsu, Kanji Nagai, Akihiko Gemma, Yuichiro Ohe, and Atsushi Ochiai
|
| 9531-9541 |
|
| Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma |
|
https://doi.org/10.18632/oncotarget.3283
Long Jiang, Shanshan Jiang, Dongrong Situ, Yongbin Lin, Han Yang, Yuanfang Li, Hao Long, and Zhiwei Zhou
|
| 9542-9550 |
|
| Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3314
Jun Li, Zhang-Jun Cheng, Yang Liu, Zhen-Lin Yan, Kui Wang, Dong Wu, Xu-Ying Wan, Yong Xia, Wan Yee Lau, Meng-Chao Wu, and Feng Shen
|
| 9551-9563 |
|
| Polymorphism in onecarbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study |
|
https://doi.org/10.18632/oncotarget.3259
Tingting Zhao, Dongying Gu, Zhi Xu, Xinying Huo, Lili Shen, Chun Wang, Yongfei Tang, Peng Wu, Jason He, Weida Gong, Ming-Liang He, and Jinfei Chen
|
| 9564-9576 |
|
| Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways |
|
https://doi.org/10.18632/oncotarget.3445
Yozo Mitsui, Hiroshi Hirata, Naoko Arichi, Miho Hiraki, Hiroaki Yasumoto, Inik Chang, Shinichiro Fukuhara, Soichiro Yamamura, Varahram Shahryari, Guoren Deng, Sharanjot Saini, Shahana Majid, Rajvir Dahiya, Yuichiro Tanaka, and Hiroaki Shiina
|
| 9577-9591 |
|
| Elevated serum CA724 levels predict poor prognosis in pancreatic adenocarcinoma after intensitymodulated radiation therapy |
|
https://doi.org/10.18632/oncotarget.3562
Peng Liu, Yuan Zhu, and Luying Liu
|
| 9592-9599 |
|
| Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study |
|
https://doi.org/10.18632/oncotarget.3292
Xi Jin, Yi-Zhou Jiang, Sheng Chen, Ke-Da Yu, Zhi-Ming Shao, and Gen-Hong Di
|
| 9600-9611 |
|
| Hypomethylation and upregulation of PD1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD1 and DNA methylation |
|
https://doi.org/10.18632/oncotarget.3324
Andreas D. Ørskov, Marianne B. Treppendahl, Anni Skovbo, Mette S. Holm, Lone S. Friis, Marianne Hokland, and Kirsten Grønbæk
|
| 9612-9626 |
|
| Head and neck cancer subtypes with biological and clinical relevance: Metaanalysis of geneexpression data |
|
https://doi.org/10.18632/oncotarget.3301
Loris De Cecco, Monica Nicolau, Marco Giannoccaro, Maria Grazia Daidone, Paolo Bossi, Laura Locati, Lisa Licitra, and Silvana Canevari
|
| 9627-9642 |
